Superior neuroprotective effects of cerebrolysin in nanoparticle-induced exacerbation of hyperthermia-induced brain pathology

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 1, 2012, Pages 7-25

  Sharma, Aruna ^a   Muresanu, Dafin Fior ^b   Mössler, Herbert ^c   Sharma, Hari Shanker ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c EVER Neuro Pharma   (Austria)

Author keywords

Blood brain barrier; Brain edema; Cerebrolysin; Heat stroke; Hyperthermia; Levetiracetam; Nanoparticles; Neuronal injuries; Neuroprotection; Pregabalin; Topiramate; Valproate

Indexed keywords

CEREBROLYSIN; ETIRACETAM; METAL NANOPARTICLE; NEUROTROPHIC FACTOR; PLACEBO; PREGABALIN; TOPIRAMATE; VALPROIC ACID;

ALZHEIMER DISEASE; ANTICONVULSANT THERAPY; ANXIETY DISORDER; APHASIA; BIPOLAR DISORDER; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN REGION; CINGULATE GYRUS; CLUSTER HEADACHE; DEGENERATIVE DISEASE; DEPRESSION; DISEASE EXACERBATION; DRUG MEGADOSE; HEAT STRESS; HEAT STROKE; HIPPOCAMPUS; HUMAN; HYPERTHERMIA; HYPOTHALAMUS; INCUBATOR; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PAIN; PARIETAL CORTEX; REVIEW; ROOM TEMPERATURE; SEIZURE; SLEEP DISORDER; STROKE; THALAMUS;

EID: 84860321062     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712799960790     Document Type: Review

References (99)

1. Armed Forces Health Surveillance Center (AFHSC). Update: heat injuries, active component, U.S. Armed Forces, 2010. MSMR.2011, 18(3), 6-8.
2. Venuto, M.; Brosch, L.C.; Tchjanda, J.; Cropper, T.L. Retrospective case series of five nontraumatic deaths among U.S. Air Force basic military trainees (1997-2007). Mil. Med., 2011, 176(8), 938-943.
3. Zeller, L.; Novack, V.; Barski, L.; Jotkowitz, A.; Almog, Y. Exertional heatstroke: clinical characteristics, diagnostic and therapeutic considerations. Eur. J. Intern. Med., 2011, 22(3), 296-299.
4. Gasparrini, A.; Armstrong, B. The impact of heat waves on mortality. Epidemiology, 2011, 22(1), 68-73.
5. Kettaneh, A.; Fardet, L.; Mario, N.; Retbi, A.; Taright, N.; Tiev, K.; Reinhard, I.; Guidet, B.; Cabane, J. The 2003 heat wave in France: hydratation status changes in older inpatients. Eur. J. Epidemiol., 2010, 25(7), 517-524.
6. Leon, L.R.; Helwig, B.G. Heat stroke: role of the systemic inflammatory response. J. Appl. Physiol., 2010, 109(6), 1980-1988.
7. Yang, T.H.; Ho, W.Y.; Shih, M.F.; Leu, K.L.; Wen, Y.S.; Liu, C.C. Effects of combination treatment with dexamethasone and mannitol on neuronal damage and survival in experimental heat stroke. Biol. Pharm. Bull., 2010, 33(9), 1522-1528.
8. Li, S.Y.; Yang, D.; Fu, Z.J.; Woo, T.; Wong, D.; Lo, A.C. Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke. Neurobiol. Dis., 2012, 45(1), 624-632.
9. Yang, T.H.; Shih, M.F.; Wen, Y.S.; Ho, W.Y.; Leu, K.L.; Wang, M.Y.; Liu, C.C. Attenuation of circulatory shock and cerebral ischemia injury in heat stroke by combination treatment with dexamethasone and hydroxyethyl starch. Exp. Transl. Stroke Med., 2010, 2(1), 19.
10. Sharma, H.S.; Muresanu, D.F.; Patnaik, R.; Stan, A.D.; Vacaras, V.; Perju-Dumbrav, L.; Alexandru, B.; Buzoianu, A.; Opincariu, I.; Menon, P.K.; Sharma, A. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J. Nanosci. Nanotechnol., 2011, 11(9), 7549-7569.
11. Keim, S.M.; Mays, M.Z.; Parks, B.; Pytlak, E.; Harris, R.M.; Kent, M.A. Heat fatalities in Pima County, Arizona. Health Place, 2007, 13(1), 288-292.
12. Lam, D.M. Heat stroke during training. Mil. Med., 1984, 149(1), 4.
13. Shibolet, S.; Lancaster, M.C.; Danon, Y. Heat stroke: a review. Aviat. Space Environ. Med., 1976, 47(3), 280-301.
14. Haboub, A.; Hallett, J.; Lowenthal, D. Thermal volatilization properties of atmospheric nanoparticles. Environ. Monit. Assess., 2007, 134(1-3), 191-197.
15. Khogali, M. Epidemiology of heat illnesses during the Makkah Pilgrimages in Saudi Arabia. Int. J. Epidemiol., 1983, 12(3), 267-273.
16. Epstein, Y.; Roberts, W.O. The pathopysiology of heat stroke: an integrative view of the final common pathway. Scand. J. Med. Sci. Sports, 2011, 21(6), 742-748.
17. Rothwell, P.M.; Algra, A.; Amarenco, P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet, 2011, 377(9778), 1681-1692.
18. Panezai, S.; Neiman, E.S.; Chokroverty, S.; Andriola, M. A practical review and approach to poststroke seizures. Rev. Neurol. Dis., 2011, 8(1-2), 10-15.
19. Lopez, G.A.; Afshinnik, A.; Samuels, O. Care of the stroke patient: routine management to lifesaving treatment options. Neurotherapeutics, 2011, 8(3), 414-424.
20. Taipa, R.; Santos, E. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures. Lupus, 2011, 20(13), 1433-1435.
21. Szaflarski, J.P.; Vannest, J.; Wu, S.W.; DiFrancesco, M.W.; Banks, C.; Gilbert, D.L. Excitatory repetitive transcranial magnetic stimulation induces improvements in chronic post-stroke aphasia. Med. Sci. Monit., 2011, 17(3), CR132-CR139.
22. Carota, A.; Staub, F.; Bogousslavsky, J. Emotions, behaviours and mood changes in stroke. Curr. Opin. Neurol., 2002, 15(1), 57-69.
23. Kim, J.S. Post-stroke pain. Expert Rev. Neurother., 2009, 9(5), 711-721.
24. Yoon, J.S.; Lee, J.H.; Son, T.G.; Mughal, M.R.; Greig, N.H.; Mattson, M.P. Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome. Neurobiol. Dis., 2011, 41(3), 624-629.
25. Zhang, T.; Jing, X.; Zhao, X.; Wang, C.; Liu, Z.; Zhou, Y.; Wang, Y.; Wang, Y. A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients. J. Affect. Disord., 2011, 136(1-2), e83-e87.
26. Tang, W.K.; Chen, Y.K.; Lu, J.Y.; Chu, W.C.; Mok, V.C.; Ungvari, G.S.; Wong, K.S. Cerebral microbleeds and depression in lacunar stroke. Stroke, 2011, 42(9), 2443-2446.
27. Liu, Y.; Barks, J.D.; Xu, G.; Silverstein, F.S. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke, 2004, 35(6), 1460-1465.
28. Khan, S.H.; Wright, S.L.; Banigesh, A.; Miyashita, H.; Todd, K.; Hemmings, S.J.; Wishart, T.; Shuaib, A. Antiischemic effects of topiramate in a transient global forebrain ischemia model: a neurochemical, histological, and behavioral evaluation. Neurochem. Res., 2003, 28(8), 1235-1239.
29. Belcastro, V.; Pierguidi, L.; Tambasco, N. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy. Brain Dev., 2011, 33(4), 289-293.
30. Abend, N.S.; Florance, N.; Finkel, R.S.; Licht, D.J.; Dlugos, D.J. Intravenous levetiracetam terminates refractory focal status epilepticus. Neurocrit. Care, 2009, 10(1), 83-86.
31. Gray, P. Pregabalin in the management of central neuropathic pain. Expert Opin. Pharmacother., 2007, 8(17), 3035-3041.
32. Roth, T.; van Seventer, R.; Murphy, T.K. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials. Curr. Med. Res. Opin., 2010, 26(10), 2411-2419.
33. Unal, O.; Deda, G.; Teber, S.; Ertem, M.; Akar, N. Thrombophilic risk factors in epileptic children treated with valproic acid. Pediatr. Neurol., 2009, 40(2), 102-106.
34. Gilad, R.; Lampl, Y.; Eschel, Y.; Sadeh, M. Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc. Dis., 2001, 12(1), 39-43.
35. Wang, Z.; Leng, Y.; Tsai, L.K.; Leeds, P.; Chuang, D.M. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J. Cereb. Blood. Flow Metab., 2011, 31(1), 52-57.
36. Reid, M.S.; Thakkar, V. Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. Drug Alcohol Depend., 2009, 102(1-3), 144-150.
37. Sharma, H.S.; Zimmermann-Meinzingen, S.; Sharma, A.; Johanson, C.E. Cerebrolysin attenuates blood-brain barrier and brain pathology following whole body hyperthermia in the rat. Acta Neurochir. Suppl., 2010, 106, 321-325.
38. Zhang, C.; Chopp, M.; Cui, Y.; Wang, L.; Zhang, R.; Zhang, L.; Lu, M.; Szalad, A.; Doppler, E.; Hitzl, M.; Zhang, Z.G. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J. Neurosci. Res., 2010, 88(15), 3275-3281.
39. Ren, J.; Sietsma, D.; Qiu, S.; Moessler, H.; Finklestein, S.P. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor. Neurol. Neurosci., 2007, 25(1), 25-31.
40. Sharma, H.S.; Zimmermann-Meinzingen, S.; Johanson, C.E. Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Ann. NY Acad. Sci., 2010, 1199, 125-137.
41. Johanson, C.; Stopa, E.; Baird, A.; Sharma, H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J. Neural Transm., 2011, 118(1), 115-133.
42. Sharma, H.S.; Ali, S.F.; Patnaik, R.; Zimmermann-Meinzingen, S.; Sharma, A.; Muresanu, D.F. Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) expression in the rat spinal cord following morphine dependence and withdrawal: possible new therapy for pain management. Curr. Neuropharmacol., 2011, 9(1), 223-235.
43. Sharma, H.S.; Zimmermann-Meinzingen, S.; Sharma, A.; Muresanu, D.F. Neuroprotective effects of cerebrolysin in animal models of CNS injuries. J. Cereb. Blood Flow Metab., 2009, 29, S423-S424.
44. Muresanu, D.F.; Zimmermann-Meinzingen, S.; Sharma, H.S. Chronic hypertension aggravates heat stress-induced brain damage: possible neuroprotection by cerebrolysin. Acta Neurochir. Suppl., 2010, 106, 327-333.
45. Sharma, H.S.; Muresanu, D.; Sharma, A.; Zimmermann-Meinzingen, S. Cerebrolysin treatment attenuates heat shock protein overexpression in the brain following heat stress: an experimental study using immunohistochemistry at light and electron microscopy in the rat. Ann. NY Acad. Sci., 2010, 1199, 138-148.
46. Sharma, H.S.; Johanson, C.E. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches. Ann. NY Acad. Sci., 2007, 1122, 112-129.
47. Muresanu, D.F.; Alvarez, X.A.; Moessler, H.; Novak, P.H.; Stan, A.; Buzoianu, A.; Bajenaru, O.; Popescu, B.O. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study. J. Neurol. Sci., 2010, 299(1-2), 179-183.
48. Alvarez, X.A.; Cacabelos, R.; Sampedro, C.; Aleixandre, M.; Linares, C.; Granizo, E.; Doppler, E.; Moessler, H. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. Eur. J. Neurol., 2011, 18(1), 59-68.
49. Hong, Z.; Moessler, H.; Bornstein, N.; Brainin, M.; Heiss, W.D.; CASTA-Investigators. A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia--CASTA. Int. J. Stroke, 2009, 4(5), 406-412.
50. Alvarez, X.A.; Sampedro, C.; Figueroa, J.; Tellado, I.; González, A.; García-Fantini, M.; Cacabelos, R.; Muresanu, D.; Moessler, H. Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury. J. Neural Transm., 2008, 115(5), 683-692.
51. Muresanu, D.F.; Alvarez, X.A.; Moessler, H.; Buia, M.; Stan, A.; Pintea, D.; Moldovan, F.; Popescu, B.O. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration. J. Neurol. Sci., 2008, 267(1-2), 112-119.
52. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Hussain, S.M.; Schlager, J.J.; Sjöquist, P.O.; Sharma, A.; Muresanu, D.F. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J. Nanosci. Nanotechnol., 2009, 9(8), 5073-5090.
53. Sharma, H.S.; Sharma, A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res., 2007, 162, 245-273.
54. Metzger, K.B.; Ito, K.; Matte, T.D. Summer heat and mortality in New York City: how hot is too hot? Environ. Health Perspect., 2010, 118(1), 80-86.
55. Bi, P.; Williams, S.; Loughnan, M.; Lloyd, G.; Hansen, A.; Kjellstrom, T.; Dear, K.; Saniotis, A. The effects of extreme heat on human mortality and morbidity in Australia: implications for public health. Asia Pac. J. Public Health, 2011, 23(2 Suppl), 27S-36S.
56. Cusack, L.; de Crespigny, C.; Athanasos, P. Heatwaves and their impact on people with alcohol, drug and mental health conditions: a discussion paper on clinical practice considerations. J. Adv. Nurs., 2011, 67(4), 915-922.
57. Tureyen, K.; Bowen, K.; Liang, J.; Dempsey, R.J.; Vemuganti, R. Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia. J. Neurochem., 2011, 116(4), 499-507.
58. Sharma, H.S. Methods to produce hyperthermia-induced brain dysfunction. Prog. Brain Res., 2007, 162, 173-199.
59. Sharma, H.S. Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches. J. Neural Transm., 2006, 113(4), 497-519.
60. Royburt, M.; Epstein, Y.; Solomon, Z.; Shemer, J. Long-term psychological and physiological effects of heat stroke. Physiol. Behav., 1993, 54(2), 265-267.
61. Bazille, C.; Megarbane, B.; Bensimhon, D.; Lavergne-Slove, A.; Baglin, A.C.; Loirat, P.; Woimant, F.; Mikol, J.; Gray, F. Brain damage after heat stroke. J. Neuropathol. Exp. Neurol., 2005, 64(11), 970-975.
62. Incorpora, G.; Pavone, P.; Ruggieri, M.; Cocuzza, M.; Mazzone, L.; Parano, E.; Privitera, M. Neonatal onset of hot water reflex seizures in monozygotic twins subsequently manifesting episodes of alternating hemiplegia. Epilepsy Res., 2008, 78(2-3), 225-231.
63. Sharma, H.S. Heat-related deaths are largely due to brain damage. Ind. J. Med. Res., 2005, 121(5), 621-623.
64. Sharma, H.S. Hyperthermia induced brain oedema: current status and future perspectives. Ind. J. Med. Res., 2006, 123(5), 629-652.
65. Sharma, H.S.; Hoopes, P.J. Hyperthermia induced pathophysiology of the central nervous system. Int. J. Hyperthermia, 2003, 19(3), 325-354.
66. Sharma, H.S.; Westman, J.; Nyberg, F. Pathophysiology of brain edema and cell changes following hyperthermic brain injury. Prog. Brain Res., 1998, 115, 351-412.
67. Guide for the Care and Use of Laboratory Animals, 8th Edition, National Research Council of the National Academies, The National Academic Press; Washington DC, 2011. www.nap.edu; http://oacu.od.nih.gov/regs/index.htm
68. Sharma, H.S.; Sharma, A.; Hussain, S.; Schlager, J.; Sjöquist, P.O.; Muresanu, D. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia. Acta Neurochir. Suppl., 2010, 106, 351-357.
69. Sharma, H.S.; Dey, P.K. Influence of long-term acute heat exposure on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Brain Res., 1987, 424(1), 153-162.
70. Sharma, H.S. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology, 1987, 26(1), 85-92.
71. Sharma, H.S.; Cervós-Navarro, J.; Dey, P.K. Acute heat exposure causes cellular alteration in cerebral cortex of young rats. Neuroreport, 1991, 2(3), 155-158.
72. Sharma, H.S.; Patnaik, R.; Sharma, A.; Sjöquist, P.O.; Lafuente, J.V. Silicon dioxide nanoparticles (SiO2, 40-50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study using pharmacological and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 4970-4980.
73. Sharma, H.S.; Dey, P.K. Probable involvement of 5- hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology, 1986, 25(2), 161-167.
74. Sharma, H.S.; Ali, S.F.; Hussain, S.M.; Schlager, J.J.; Sharma, A. Influence of engineered nanoparticles from metals on the bloodbrain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 5055-5072.
75. Wang, H.; Gao, J.; Lassiter, T.F.; McDonagh, D.L.; Sheng, H.; Warner, D.S.; Lynch, J.R.; Laskowitz, D.T. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit. Care, 2006, 5(1), 71-78.
76. Sharma, H.S.; Patnaik, R.; Sharma, A. Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol., 2010, 10(12), 7931-7945.
77. Sharma, H.S.; Kiyatkin, E.A. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat., 2009, 37(1), 18-32.
78. Kiyatkin, E.A.; Sharma, H.S. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience, 2009, 161(3), 926-939.
79. Sharma, H.S.; Miclescu, A.; Wiklund, L. Cardiac arrest-induced regional blood-brain barrier breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and neuroprotection in porcine brain. J. Neural Transm., 2011, 118(1), 87-114.
80. Adams, J.H.; Duchen, L.W. Greenfield's Neuropathology. 5th edn. Edward Arnold; 1992, pp. 1-1557.
81. Sharma, H.S. Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J. Neural Transm., 2011, 118(1), 155-176.
82. Sharma, H.S.; Westman, J. The Blood-Spinal Cord and Brain Barriers in Health and Disease. Academic Press; San Diego, 2004, pp. 1-617.
83. Sharma, H.S. Pathophysiology of blood-brain barrier, brain edema and cell injury following hyperthermia: New role of heat shock protein, nitric oxide and carbon monoxide. An experimental study in the rat using light and electron microscopy, Acta Univ. Ups., 1999, 830, 1-94.
84. Sharma, H.S.; Sharma, A. Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. In: Ritsner, M., Ed.; Brain Protection in Schizophrenia, Mood and Cognitive Disorders; Springer-Verlag, Berlin, New York, 2010, pp. 243-304.
85. Sharma, H.S. Blood Central Nervous System Barriers: The Gateway to Neurodegeneration, Neuroprotection and Neuroregeneration, In: Lajtha, A.; Banik, N.; Ray, S.K., Eds; Handbook of Neurochemistry and Molecular Neurobiology: Brain and Spinal Cord Trauma. Springer Verlag, Berlin, Heidelberg, New York, 2009, pp. 363-457.
86. Muresanu, D.F.; Sharma, A.; Sharma, H.S. Diabetes aggravates heat stress-induced blood-brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Ann. NY Acad. Sci., 2010, 1199, 15-26.
87. Muresanu, D.F.; Sharma, H.S. Chronic hypertension aggravates heat stress induced cognitive dysfunction and brain pathology: an experimental study in the rat, using growth hormone therapy for possible neuroprotection. Ann. NY Acad. Sci., 2007, 1122, 1-22.
88. Sharma, H.S. Nanoneuroscience and nanoneuropharmacology. Prog. Brain Res., 2009, 180, 1-286.
89. Sharma, H.S.; Muresanu, D.F.; Sharma, A.; Patnaik, R.; Lafuente, J.V. Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res., 2009, 180, 154-180.
90. Sharma, H.S. A special section on nanoneuroscience: nanoneurotoxicity and nanoneuroprotection. J. Nanosci. Nanotechnol., 2009, 9(8), 4992-4995.
91. Alm, P.; Sharma, H.S.; Sjöquist, P.O.; Westman, J. A new antioxidant compound H-290/51 attenuates nitric oxide synthase and heme oxygenase expression following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat. Amino Acids, 2000, 19(1), 383-394.
92. Sharma, H.S.; Westman, J.; Alm, P.; Sjöquist, P.O.; Cervós-Navarro, J.; Nyberg, F. Involvement of nitric oxide in the pathophysiology of acute heat stress in the rat. Influence of a new antioxidant compound H-290/51. Ann. NY Acad. Sci., 1997, 15, 581-590.
93. Sharma, H.S.; Gordh, T.; Wiklund, L.; Mohanty, S.; Sjöquist, P.O. Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. J. Neural Transm., 2006, 113(4), 521-536.
94. Leker, R.R.; Neufeld, M.Y. Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Res. Brain Res. Rev., 2003, 42(3), 187-203.
95. McLean, M.J.; Bukhari, A.A.; Wamil, A.W. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia, 2000, 41(Suppl 1), S21-S24.
96. Johannessen, L.C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs, 2008, 22(1), 27-47.
97. Di Guilmi, M.N.; Urbano, F.J.; Inchauspe, C.G.; Uchitel, O.D. Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of ca(v)2.1 calcium channels. J. Pharmacol. Exp. Ther., 2011, 336(3), 973-982.
98. Lyseng-Williamson, K.A. Levetiracetam: a review of its use in epilepsy. Drugs, 2011, 71(4), 489-514.
99. Menon, P.K. Effects of Cerebrolysin, a mixture of neurotrophins on spinal cord injury in relation to nanoparticles treatment. Master's Thesis, Uppsala University: Uppsala, Sweden, pp.1-28.